Plexera, MitoSciences to Develop Mitochondrial Antibody Array for ADME/Tox | GenomeWeb
NEW YORK (GenomeWeb News) – Lumera subsidiary Plexera Bioscience said today that it has struck an agreement with MitoSciences to develop an antibody array based on Plexera’s ProteomicProcessor biosensor technology and MitoSciences’ antibodies.
 
Plexera said the development agreement is “in conjunction with” a previous agreement under which parent firm Lumera partnered with the Medical University of South Carolina to develop a protein-expression profiling assay.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.